IP Library Granted Patent US 11,129,940
Granted Patent B2
US 11,129,940 · App. 15/501,333 · Granted Sep 28, 2021

Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes

Inventor: Martin Donovan (Austin, TX)
Assignee: Xeris Pharmaceuticals, Inc.
A61M5/281A61K9/0024A61K47/14A61K47/26A61M5/178A61M5/28A61M5/315A61M5/329A61M5/344A61M2202/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,129,940
App. No.
15/501,333
Granted
Sep 28, 2021
Kind
B2
Abstract

This disclosure includes syringes, kits containing the same, and related methods. Some syringes are pre-loaded with paste and have a syringe body defining a reservoir having an internal first transverse dimension, a paste disposed within the reservoir, the paste having a solids concentration of greater than 50 mg/mL, a needle defining a lumen having an internal second transverse dimension that is smaller than the first transverse dimension, the needle configured to be in fluid communication with the reservoir to allow intracutaneous delivery of the paste, and a plunger and/or piston disposed within the reservoir and configured to be moved to dispense paste from the reservoir through the lumen. Some syringes include a fitting (e.g. Luer fitting) disposed on the syringe body and in fluid communication with the reservoir and a sealing cap disposed on the Luer fitting to seal the reservoir.

Claims (28)

1. A pre-loaded syringe, said syringe pre-loaded with a paste, comprising:

a syringe body defining a reservoir having an internal first transverse dimension;

a paste disposed within the reservoir, the paste having a volume of between 15 μL and 2000 μL, a stiff consistency, and a solids concentration of greater than 50 mg/mL;

a plunger disposed within the reservoir and configured to be moved to dispense paste from the reservoir;

a Luer fitting disposed on the syringe body and in fluid communication with the reservoir;

a sealing cap disposed on the Luer fitting to seal the reservoir; and

a needle defining a lumen having an internal second transverse dimension, the needle configured to be coupled to the syringe body via the Luer fitting to allow intracutaneous delivery of the paste;

wherein the internal first transverse dimension of the reservoir is 3 to 20 times larger than the internal second transverse dimension of the lumen of the needle; and

wherein the syringe is configured to dispense the paste at a flow rate of greater than 30 μL/s or greater than 65 μL/s under a force applied to the plunger having a magnitude below 50 N.

2. The pre-loaded syringe of claim 1 , wherein the solids concentration of the paste is greater than 100 mg/mL.

3. The pre-loaded syringe of claim 1 , where the first transverse dimension is between 1 and 10 mm.

4. The pre-loaded syringe of claim 1 , where the second transverse dimension is between 0.1 and 0.9 mm.

5. The pre-loaded syringe of claim 1 , where the needle has a size of 18 Gauge, 27 Gauge, 30 Gauge, or smaller.

6. The pre-loaded syringe of claim 1 , where the needle has a length smaller than 50 mm, 40 mm, or 13 mm.

7. The pre-loaded syringe of claim 6 , where the needle has a length of approximately 6 mm.

8. The pre-loaded syringe of claim 1 , where the paste has a volume greater than 50 μL or greater than 100 μL.

9. The pre-loaded syringe of claim 1 , where the paste has a solids concentration of greater than 200 mg/mL.

10. The pre-loaded syringe of claim 9 , where the paste has a solids concentration of between 300 and 500 mg/mL.

11. The pre-loaded syringe of claim 1 , where the paste has a solids content of between 1% and 99%.

12. The pre-loaded syringe of claim 11 , where the paste has a solids content of between 30% and 50%.

13. The pre-loaded syringe of claim 1 , where the paste has a density of between 1.1 and 1.4 g/mL.

14. A kit comprising:

the pre-loaded syringe of claim 1 , where the paste has a solids concentration of greater than 100 mg/mL.

15. A method of intracutaneously injecting a volume of paste comprising:

moving the plunger of the pre-loaded syringe of claim 1 to dispense paste from the reservoir of the syringe through the lumen of the needle of the syringe, where the internal first transverse dimension of the reservoir is between 1 and 10 mm and the internal second transverse dimension is between 0.1 and 0.9 mm;

where the paste has a solids concentration of greater than 100 mg/mL; and

where the paste is dispensed at a flow rate of greater than 30 μL/s as the plunger is moved at a rate of between 2 and 40 mm/s.

16. The pre-loaded syringe of claim 1 , wherein the force applied to the plunger has a magnitude below 25 N.

Assignments (4)
REASSIGNMENT AND RELEASE OF SECURITY INTEREST Recorded Mar 10, 2022
From: OXFORD FINANCE LLC
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 059358/0700 →
SECURITY INTEREST Recorded Mar 9, 2022
From: XERIS PHARMACEUTICALS, INC.; STRONGBRIDGE DUBLIN LIMITED
To: HAYFIN SERVICES LLP
Reel/Frame 059552/0066 →
SECURITY INTEREST Recorded Sep 12, 2019
From: XERIS PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 050362/0445 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2019
From: DONOVAN, MARTIN
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 048460/0152 →